Trump’s tar­iff im­pact like­ly ‘min­i­mal’ for brand-name drug­mak­ers, man­u­fac­tur­ing part­ners

Sev­er­al brand-name drug­mak­ers be­lieve they will with­stand any drug pric­ing im­pacts from Pres­i­dent Don­ald Trump’s tar­iffs — and man­u­fac­tur­ers that con­tract with phar­ma com­pa­nies will like­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER